Goutifade (Febuxostat) is approved by FDA amp; EULAR as a new era in the management of gout amp; hyperuricemia with fast onset action amp; great safety profile with elderly, hepatic amp; renal impairment patients .


Indication: treatment of hyperuricaemia in conditions where urate deposition has already occured.dose: 1 tablet once daily